Lab offers COVID-19 return-to-work testing services
Quest Diagnostics today announced new workplace services to aid return-to-work efforts, including access to specimen collection options for COVID-19 testing and on-site temperature checks.
The lab said it currently has capacity to perform 200,000 antibody tests per day and is ramping up lab operations with the goal of performing 150,000 molecular diagnostic tests per day by the end of June.
The Centers for Disease Control and Prevention warns that antibody tests may not show whether individuals are immune and should not be the sole basis for decisions about a person’s return to a workplace.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…